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ABSTRACT
Background  Ankylosing spondylitis (AS) is a chronic inflammatory condition charac-
terised by spinal arthritis and exercise is often recommended to reduce the symptoms 
and improve mobility. However, very little evidence exists for the value of exercise in AS. 
Objectives Firstly, this pilot study aimed to evaluate an eHealth tool, the AS 
Observer, specifically designed  to monitor symptoms, quality of  life and physical 
activity in AS, in terms of patient experience and suitability in generating data for 
epidemiological studies. Secondly, it also investigated the collected data to deter-
mine if physical activity benefited individuals with AS. 
Methods The AS Observer was designed to enable weekly monitoring of AS 
symptoms and exercise using a web based platform. Participants with AS (n = 223) 
were recruited to use the AS observer. They provided baseline data and completed 
online weekly data entry for 12 weeks (e.g. Bath Ankylosing Spondylitis Activity Index 
(BASDAI), howRu, International Physical Activity Questionnaire (IPAQ)). Panel data 
analysis with fixed effects models investigated associations between variables. Activity 
type data and exit questionnaires were subjected to qualitative thematic analysis.
Results In general, the AS Observer was well received and considered useful by 
participants, with 66% providing a positive response. The collected data suggested 
that IPAQ is inversely associated with total BASDAI, stiffness, tenderness and pain, 
but not fatigue. Stratified analysis demonstrated differential associations between 
BASDAI, IPAQ and howRU based on sex, HLA-B27 status and disease duration. 
Approximately  half  of  the  participants  frequently  did  therapy  and  three-quarters  
undertook at least some vigorous activity ranging from formal exercise to recreation 
and (house) work. Despite some technical challenges, tool evaluation suggested 
that the AS Observer was a useful self-monitoring tool for participants. 
Conclusions This pilot study demonstrated that increased exercise intensity and 
duration were associated with an improved BASDAI symptom score in a cohort of 
participants with AS. Furthermore, it provided further evidence of the value of using 
eHealth tools for clinical purposes and data collection for research, inclusive of the 
development of treatment pathways and disease management strategies. 
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INTRODUCTION
Ankylosing spondylitis (AS), which is the prototype of 
the  seronegative  spondyloarthropies,  is  an  inflammatory 
condition characterised by spinal arthritis and associated 
conditions such as uveitits and Crohn’s disease.1 The 
prevalence of AS is reported as 0.24% in Europe2 and 
0.27%  in  the UK. AS  is a  chronic  inflammatory  condition 
with a heavy burden of disease3 that includes sacroiliitis, 
spinal fusion, peripheral arthritis and a range of extra-artic-
ular manifestations,4 ultimately leading to impacts upon 
mobility, societal functioning, mental health and elevated 
mortality.5 Understanding of AS aetiology and pathogene-
sis is still limited. However, hereditary polygenic character-
istics have been recognised, most notably the association 
with Human Leukocyte Antigen gene (HLA-B27),6 which is 
often used within diagnosis criteria.7 
Exercise and physiotherapy are commonly used in managing 
AS to maintain spinal mobility, reduce pain and support men-
tal health. Studies have shown a positive correlation between 
the amount of exercise and improvement of symptoms, spinal 
movement, flexibility and strength during individual and super-
vised exercise programmes (including physiotherapy) for a 
duration of between two and six months.8,9 However, a recent 
systematic review undertaken to support recommendations 
for the management of AS noted that despite these positive 
findings ‘the small numbers of participants, the heterogeneity 
of the interventions and outcome measures, and deficiency in 
reporting data result in wide intervals and lack of strong evi-
dence’,10 eHealth, which is the use of information and com-
munication technologies to investigate health, may provide 
solutions to address concerns raised by the systematic review. 
Mobile phone applications and websites are increasingly 
being utilised to allow patients to monitor their condition and 
other aspects of their lives on a daily basis, thus generating 
large longitudinal datasets for analysis and therefore improv-
ing our understanding of particular conditions. The availability 
of self-assessment technology is increasing and as eHealth 
accessibility is improving, prevention, treatment and health 
maintenance is becoming personalised and patient tailored.11 
Studies show that there has been an upward trend in using the 
internet for health-related purposes12 and that small studies 
with a direct focus improve the efficacy and accuracy of clinical 
support for long-term conditions.13
This pilot study aimed to determine whether the AS 
Observer (https://asobserver.wordpress.com/home/), a 
specially developed online tool, was suitable to monitor the 
symptoms, health-related quality of life and physical activity 
of participants with AS. The study also utilised the data col-
lected to investigate whether physical activity influenced the 
symptoms and quality of life of individuals with AS. 
METHODS
The online AS Observer tool, a web-based participant engage-
ment interface, was developed in collaboration with myClini-
calOutcomes Ltd (mCO; http://www.myclinicaloutcomes.com). 
The mCO system is designed to support real-life clinical 
workflows by collecting core clinical metrics at timely intervals 
along the diagnosis and treatment pathway, displaying this 
data on tailored patient and clinician interfaces.14 This was 
modified to produce the AS Observer module, with the clini-
cian interface replaced with a researcher dashboard enabling 
the research team to login and investigate some basic sum-
mary statistics during the 12-week data collection phase. 
Participants meeting the inclusion criteria (aged 18+, diag-
nosed with AS, U.K. resident and with computer access) 
were invited to participate via email (with assistance from the 
National Ankylosing Spondylitis Society; NASS) and social 
media  (e.g. AS  forums).  They were  directed  to  the  project 
website (https://asobserver.wordpress.com/home/) where 
information on project goals, ethical  information and how to 
participate was available.
Registration and baseline data
At registration, consenting participants were allocated a 
unique  identifier  code and baseline  data  (e.g.  sex,  date  of 
birth, year of diagnosis, body mass index (BMI),  smoking 
status (never, former and current), disease severity  proxies 
(i.e. HLA-B27 status, frequency of attendance at rheumatol-
ogy clinic and current medications) and comorbidities (using 
Department  of  Health  standardised  question  set)  were 
 collected15 using the patient interface of the mCO  system 
(Figure 1).
Weekly question set
Data was collected for 12 weeks from 15 September to 7 
December 2014. Weekly email reminders were sent to par-
ticipants  requesting  them  to  fill  out  three  assessments  on 
the patient interface. These assessments included the Bath 
Ankylosing Spondylitis Disease Activity Index (BASDAI) as 
a measure of current disease activity (Figure 2),16 health-
related quality of life was monitored via howRu (http://www. 
r-outcomes.com; four components: pain or discomfort, feel-
ing low or worried, limited in what you can do and require help 
from others) and physical activity via the validated short form 
of the International Physical Activity Questionnaire (IPAQ; 
http://www.ipaq.ki.se/ipaq.htm),  which  assesses  physical 
activity frequency,  intensity and duration. The howRu ques-
tions have better readability statistics and a similar overall 
performance when based on a single point in time compared 
with the longer SF1217 and EQ-5D.18 Additionally, an open 
text question was added to the IPAQ to capture the different 
activity types patients were undertaking. 
Total Metabolic Equivalent of Task (MET) minutes of exer-
cise per week variable  (which was subsequently  log  trans-
formed) and IPAQ categories (low, moderate or high intensity 
exercise) were calculated following the IPAQ scoring proto-
cols.19 A binary vigorous activity variable was also derived 
looking at participants who had done more than 1 hour of 
vigorous activity per week.20 
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Figure 2 Screen shot of the patient interface for weekly reporting of the symptoms of AS (using the BASDAI score), health 
and wellbeing (using howRu) and physical activity (using IPAQ) 
Figure 1 Screenshots of the my clinical outcomes web-based tool for monitoring ankylosing spondylitis and 
physical activity
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Tool evaluation
To facilitate evaluation of the eHealth tool any comments 
on the website or contact with the help desk were recorded. 
Additionally, all participants including those withdrawing 
before the end of the study received a set of exit questions 
to ascertain the validity and usability of the AS observer 
(Table S1). The  answers  to  these  questions were  investi-
gated using qualitative techniques. Coding frameworks were 
developed by utilising thematic analysis with an inductive 
content analysis approach on manifest content. This con-
sisted of rounds of data familiarisation, open coding, theme 
construction, abstraction and interpretation21 and allowed 
identification of similarities in data and the development of 
thematic patterns.22 Where appropriate, counts were per-
formed on the number of participants whose responses 
aligned with each code.
Statistical analysis – physical activity  
and AS
All statistical analysis utilised a panel data analysis 
approach  and  the  ‘xt’  suite  of  functions  in  Stata  V13.1. 
Descriptive statistics were generated for demographic char-
acteristics of participants. Associations between categori-
cal demographic characteristics and total mean BASDAI 
score (0–10) were ascertained using regression analyses. 
Fixed effect (FE) regression models investigated associa-
tions between BASDAI (and its individual components, i.e. 
fatigue, pain, stiffness and tenderness) and physical activ-
ity measures (IPAQ – continuous and categorical, 1 hour of 
vigorous activity). The FE models reduce bias by removing 
the effect of time invariant variables (e.g. demographics). 
Regression models were  therefore only adjusted  for con-
founding variables that altered weekly (e.g. howRu, physi-
cal activity or BASDAI). The association between howRu 
and total BASDAI or physical activity were assessed using 
FE regression models. 
Stratified analyses were performed on sex, HLA-B27 sta-
tus and disease duration (0–10; 11+ years). Following quali-
tative analysis of activity type, some stratified analyses were 
performed investigating a number of themes including gar-
dening, team sports and housework. 
A sensitivity analysis was also performed investigating 
associations only in participants that had completed at least 
6 weeks of data.
RESULTS AND DISCUSSION 
In this pilot study, 223 individuals were recruited and on aver-
age this cohort was 50 years old, which had been diagnosed 
17 years ago, and of those who knew their HLA-B27 status 
81% were positive (Table 1). At least half of participants could 
be considered to have active AS requiring management (52% 
attended a clinic at least twice a year and 38% were using 
anti-TNFα therapies). The majority of participants had comor-
bidities (75%), including chronic back pain, sciatica or osteo-
porosis (45%), cardiovascular problems (43%) and stomach 
or bowel problems (40%). The mean BASDAI, howRu score 
and IPAQ MET minutes reported over the 12-week period are 
summarised in Table 1. 
Associations between demographic characteristics and 
BASDAI  (Table  2)  were  generally  as  expected,  with  signifi-
cantly elevated BASDAI scores observed in those with higher 
BMIs and those with more frequent rheumatology clinic visits 
or high numbers of comorbidities.23 Medication use did not cor-
relate with levels of disease activity, except for patients using 
steroids who had the highest mean BASDAI (5.20 ± 2.15). 
Physical activity, BASDAI and mental health
Higher physical  activity  levels were  significantly  associated 
with lower BASDAI even when adjusting for howRU (Table 3 
and Figure 3). This supports previous studies where exercise 
or active lifestyles (even if formal exercise was minimal) have 
supported the management of AS.24 At least 1 hour of vigor-
ous activity per week also lowered disease activity to below 
the clinical cutoff BASDAI 4 indicating the need for treatment 
review (mean BASDAI = 3.31 ± 2.07 versus 4.3 ± 2.17). 
Analysis of the individual components of BASDAI suggested 
that  physical  activity  benefited  pain,  stiffness  and  tender-
ness, but not fatigue (Table 3). This contrasts with previous 
reports,25 where physical activity did improve fatigue levels. 
The association with peripheral and axial pain and activity 
was  lost when  adjusting  the models  for  the  howRU  score, 
thus demonstrating the importance that mental health plays 
in the experience of pain.26
Health-related  quality  of  life  scores  were  very  strongly 
inversely associated with BASDAI (Figure 4). A one-unit 
increase in the total howRu score was associated with a 
0.56 (95%CI 0.50, 0.62, P < 0.001) reduction in the BASDAI 
score. Increased physical activity was associated with 
improved overall quality of life (Figure 5) and less pain, even 
when adjusted for BASDAI (Table 4). This fits with previous 
research  where  quality  of  life  was  found  to  very  strongly 
associate with self-reported disease activity,27 and physical 
activity was noted to improve mental health.26 These findings 
may indicate that undertaking physical activity even during 
periods of higher disease activity is beneficial especially for 
quality of life.
Interestingly, physical activity did not affect the feeling of 
dependency (Table 4). This may be due to the longer term 
effects of living with AS, including concerns around the 
future,28 impacting an individual’s perception of their inde-
pendence regardless of whether their view of how capable 
they are changes. 
Types of physical activity
Qualitative data analysis on activity types resulted in the gen-
eration of a coding framework consisting of five themes, which 
applied across all activity intensities: exercise, recreation / 
hobbies, household (or work) activities, care activities, none 
and an ‘uncategorised’ for unsuitable listings. For each activity, 
intensity-level codes were generated within each theme and 
the range of formal exercise listed was extensive. The most 
frequently  noted  categories  across  moderate  and  vigorous 
levels were biking = running/walking > therapy > water-based 
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Figure 3 Bar chart showing the change in BASDAI score per quintile of IPAQ. There was an inverse relationship between 
the two with more exercise resulting in a lower BASDAI score. This was shown to be statistically significant in linear 
regression models (Table 3)
Figure 4 Dot plot of mean BASDAI score against howRu score. Error bars represent ± 1 standard deviation
Figure 5 Dot plot representing mean howRu score per decile of the IPAQ physical activity measure. Error bars represent 
± 1 standard deviation
sports > gym > land exercise classes > calisthenics > racquet 
games > ball games > contact sports (Table S2). Solo activi-
ties far outweighed team activities and this may reflect the vari-
able nature of AS. Solo activities tend to require less planning 
and prior commitment, and therefore individuals can choose 
to partake depending on their daily wellness. Additionally, 
it  may  reflect  feelings  of  confidence  in  abilities  due  to  the 
 noncompetitive nature of solo activities.28,29
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Table 1 Demographic characteristics of AS observer 
participants
Total, n 223
Mean age at recruitment in years (SD) 50.2 (13.9)
Mean disease duration in years (SD) 16.9 (14.2)
Sex
 Male, n (%) 136 (61.0)
 Female, n (%) 87 (39.0)
Mean BMI* (SD) 26.7 (5.4)
Smoking status
 Never, n (%) 126 (56.5)
 Former, n (%) 78 (35.0)
 Current, n (%) 19 (8.5)
HLA-B27 Status
 Positive, n (%) 120 (53.8)
 Negative, n (%) 28 (12.6)
 Unknown, n (%) 75 (33.6)
Diagnosed by
 Consultant, n (%) 194 (87.0)
 GP, n (%) 29 (13.0)
Frequency of rheumatology visits
 Less than twice a year, n (%) 107 (48.0)
 Twice a year, n (%) 73 (32.7)
 More than twice a year, n (%) 43 (19.3)
Medications**
 Biologics (Anti-TNF), n (%) 84 (37.8)
 Steroids, n (%) 15 (6.8)
 DMARDs, n (%) 6 (2.7)
 Painkillers, n (%) 117 (52.7)
Mean comorbidities, (SD) 2.1 (2.1)
 Mean number of tool uses, (SD; range) 8 (3; 1–12)
 Mean BASDAI, (SD; range) 3.9 (2.1; 0–9)
 Mean IPAQ, (SD; range)*** 4,117 (5,683; 0–62,582)
 Mean howRu (SD; range) 8.5 (2.1; 1.8–12)
*BMI data was not available for 18 participants, and an 
 additional two participants were excluded as the reported 
height and weight gave BMIs substantially outside of normal 
ranges, i.e. BMIs of 4 and 198
**indicates primary medication listed by participants from 
dropdown list; n = 222 for medications as one participant did 
not complete data entry. Medication options were as follows: 
simple oral pain killer tablets, e.g. aspirin or paracetamol; oral 
anti-inflammatory  (NSAIDs)  tablets,  e.g.  diclofenac,  ibupro-
fen or naproxen; Opioid medication, e.g. morphine tablets or 
patches or tramadol; DMARDs (disease modifying anti-rhe 
umatic drugs) Methotrexate and/or Sulphasalazine; Oral ste-
roid tablets; Steroid injection; Biologic therapy – Adalimumab 
(Humira), Etanercept (Enbrel), Golimumab (Simponi) or 
Infliximab (Remicade)
***Analysed on the log scale but converted back to MET 
minutes per week here
Table 2 Associations between demographic characteristics 
and disease severity (total continuous BASDAI) 
Mean (SD) BASDAI P
Disease duration 0.06
 0–10 years 3.76 (1.94)
 11–20 years 4.17 (1.92)
 21+ years 3.94 (2.28)
Sex 0.08
 Male 3.70 (2.21)
 Female 4.22 (1.80)
Smoking Status 0.66
 Never 3.89 (2.15)
 Former 3.84 (2.00)
 Current 4.05 (1.84)
BMI <0.001
 Normal 3.03 (1.77)
 Overweight 4.18 (2.12)
 Obese 5.0 (1.62)
 Severely obese 5.22 (1.95)
HLA-B27 status 0.37
 Positive 3.93 (2.13)
 Negative 3.54 (1.71)
Rheumatology frequency <0.001
 Less than twice a year 3.35 (1.90)
 Twice a year 4.21 (2.19)
 More than twice a year 4.79 (1.90)
Comorbidities <0.001
 0 2.98 (1.78)
 1–3 3.88 (1.92)
 4+ 5.42 (2.44)
Anti-TNF 0.07
 Yes 3.54 (1.92)
 No 4.07 (2.16)
Steroids 0.01
 Yes 5.20 (2.15)
 No 3.79 (2.05)
DMARDss 0.52
 Yes 4.41 (2.71)
 No 3.86 (2.06)
Painkillers 0.83
 Yes 3.91 (2.37)
 No 3.85 (2.04)
*Medication options were as listed in Table 1 footnote
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Table 3 Associations between physical activity and disease severity measures
Association between BASDAI (outcome) and IPAQ (predictor)
FE model; crude P Adjusted* P
Log IPAQ −0.18 (−0.27, −0.09) <0.001 −0.10 (−0.18, −0.02) 0.013
IPAQ category −0.12 (−0.23, −0.00) 0.046 −0.04 (−0.14, 0.07) 0.49
Vigorous activity −0.21 (−0.38, −0.04) 0.029 −0.16 (−0.31, −0.01) 0.037
Association between BASDAI Fatigue (outcome) and IPAQ (predictor)
Log IPAQ −0.11 (−0.23, 0.01) 0.07 −0.03 (−0.14, 0.08) 0.63
IPAQ category −0.08 (−0.23, 0.07) 0.29 0.00 (−0.14, 0.14) 0.99
Vigorous activity −0.13 (−0.35, 0.10) 0.26 −0.08 (−0.29, 0.14) 0.49
Association between BASDAI stiffness (outcome) and IPAQ (predictor)
Log IPAQ −0.19 (−0.28, −0.09) <0.001 −0.11 (−0.20, −0.03) 0.01
IPAQ category −0.19 (−0.32, −0.07) 0.002 −0.12 (−0.23, -0.01) 0.041
Vigorous activity −0.16 (−0.34, 0.03) 0.091 −0.11 (−0.28, 0.06) 0.20
Association between BASDAI axial pain (outcome) and IPAQ (predictor)
Log IPAQ −0.17 (−0.29, −0.05) 0.005 −0.08 (−0.18, 0.03) 0.17
IPAQ category −0.15 (−0.30, 0.01) 0.06 −0.05 (−0.19, 0.09) 0.46
Vigorous activity −0.15 (−0.38, 0.07) 0.19 −0.09 (−0.30, 0.12) 0.38
Association between BASDAI other pain (outcome) and IPAQ (predictor)
Log IPAQ −0.12 (−0.24, −0.01) 0.032 −0.06 (−0.17, 0.05) 0.31
IPAQ category −0.05 (−0.20, 0.10) 0.52 0.02 (−0.13, 0.16) 0.82
Vigorous activity −0.17 (−0.39, 0.05) 0.12 −0.13 (−0.34, 0.08) 0.23
Association between BASDAI tenderness (outcome) and IPAQ (predictor)
Log IPAQ −0.23 (−0.34, −0.12) <0.001 −0.15 (−0.26, −0.05) 0.004
IPAQ category −0.15 (−0.30, −0.01) 0.034 −0.08 (−0.22, 0.05) 0.24
Vigorous activity −0.17 (−0.38, 0.04) 0.12 −0.12 (−0.32, 0.08) 0.23
The log IPAQ scores given represent METs minutes per week; IPAQ categories 
 consisted of low, medium and high as described in methods. Regression coefficients 
and the associated 95% confidence intervals are represented along with P values. 
*Adjusted for howRU
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Table 4 Associations between physical activity and health-related quality of life
Association between howRU (outcome) and IPAQ (predictor)
FE Model; Crude P Adjusted* P
Log IPAQ 0.20 (0.10, 0.30) <0.001 0.10 (0.01, 0.19) 0.029
IPAQ category 0.20 (0.07, 0.33) 0.003 0.14 (0.02, 0.26) 0.024
Vigorous activity 0.13 (−0.07, 0.33) 0.19 0.01 (−0.16, 0.19) 0.87
Association between howRU pain (outcome) and IPAQ (predictor)
Log IPAQ 0.07 (0.03, 0.11) <0.001 0.04 (0.01, 0.08) 0.025
IPAQ category 0.08 (0.03, 0.13) 0.002 0.06 (0.01, 0.11) 0.012
Vigorous activity 0.06 (−0.02, 0.14) 0.13 0.02 (−0.05, 0.09) 0.54
Association between howRU Dependent on Others (outcome) and IPAQ (predictor)
Log IPAQ 0.03 (0.00, 0.06) 0.05 0.01 (−0.02, 0.04) 0.34
IPAQ category 0.03 (−0.01, 0.07) 0.12 0.02 (−0.02, 0.06) 0.28
Vigorous activity 0.05 (−0.01, 0.11) 0.13 0.03 (−0.03, 0.09) 0.36
Association between howRU Limited (outcome) and IPAQ (predictor)
Log IPAQ 0.04 (0.01, 0.08) 0.026 0.01 (−0.02, 0.05) 0.52
IPAQ category 0.04 (−0.01, 0.09) 0.13 0.02 (−0.03, 0.06) 0.43
Vigorous activity −0.02 (−0.09, 0.06) 0.65 −0.05 (−0.12, 0.01) 0.11
Association between howRU Feel Low (outcome) and IPAQ (predictor)
Log IPAQ 0.05 (0.01, 0.10) 0.02 0.03 (−0.01, 0.08) 0.14
IPAQ category 0.05 (−0.01, 0.11) 0.1 0.04 (−0.02, 0.09) 0.22
Vigorous activity 0.04 (−0.04, 0.13) 0.34 0.02 (−0.07, 0.10) 0.66
The log IPAQ scores given represent METs minutes per week; IPAQ categories  consisted 
of  low,  medium  and  high  as  described  in  methods.  Regression  coefficients  and  the 
 associated 95% confidence intervals are represented along with P values.
*Adjusted for BASDAI
Stratified analysis
Stratification  of  data  by  sex  (Table  5)  demonstrated  that 
BASDAI in women was inversely associated with continu-
ous IPAQ scores. However, this was not seen in men where 
more vigorous activity was  required  to see  improvements  in 
BASDAI. This may be partially explained by physical activ-
ity reducing symptoms that are more common in women, i.e. 
neck, knees and hip pain and tenderness.30 Physical activity 
benefitted  health-related  quality  of  life  for  men,  with  higher 
levels of physical activity improving howRu scores, but this 
association was not seen in women. This may be due to dif-
ferences in the profile of AS symptoms typically seen in men 
and women.30
Associations between physical activity levels, BASDAI 
and  quality  of  life  were  significant  for  individuals  who  were 
HLA-B27 positive (Table 5). No relationship was observed for 
HLA-B27 negative; however, numbers were low (28 par-
ticipants). Additionally, in individuals with a disease duration 
of >10 years, physical activity significantly benefited quality of 
life, but not BASDAI. More recently, diagnosed participants 
doing an hour or more of vigorous activity per week associated 
with improved BASDAI, but negatively associated with quality 
of life. This may suggest that at early stages of the disease, 
physical activity negatively impacts the individual, possibly 
via the interaction of pain and mental health. Furthermore, 
individuals recording vigorous or moderated gardening 
(n = 98 versus no vigorous or moderate gardening n = 125) 
as one of  their more  frequent activities had higher average 
log IPAQ scores (7.91 ± 0.93 versus 7.59 ± 0.99) and lower 
disease activity (BASDAI = 3.59 ± 2.1 versus 4.18 ± 2.0). 
Tool evaluation
Participant experience of using the AS Observer tool was 
 generally positive, with the large majority (66 %)  expressing intent 
to continue using it, either for the purposes of  self-monitoring 
tool, active disease management (e.g. identifying triggers), to 
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raise awareness of their own condition or as a motivator to 
undertake physical activity.
Withdrawal and completion rates
Only three participants chose to withdraw from the study 
before completion and these were all due to technical issues 
(including only having access to a phone, not a computer 
and failure of the site to load on particular browsers). The 
large  majority  of  participants  did  not  complete  data  entry 
every week with an average completion rate of 67%, i.e. 8 of 
12 weeks  (42% completed ≤ half, 55% completed 7–9 of 12  
data entries, and only 3% completed 11 or 12). This fits with 
previous eHealth studies of web-based monitoring, with 
adherence rates ranging between 30% and 75%.31 All par-
ticipants who answered exit  questions appreciated  the use 
of reminder emails; however, technical problems prevented 
some reminder emails being delivered in the last few weeks 
(reported by 20% of participants) and likely contributed to a 
drop in compliance. Not receiving reminder emails (including 
delivery to spam folders) was the main reason given by par-
ticipants for skipping reporting (44%, Table 6) and this illus-
trates how important the inclusion of the reminder or prompt 
mechanism is for effective data collection in eHealth tools.
Participant experience
Exit  questionnaires  obtained  from  those  withdrawing  early 
(n = 1) and participants at the end of study (n = 92; 41%) were 
tabulated  and  coded  for  each  question. Aside  from partici-
pants who declined to answer (n = 33), the majority intended 
to continuing using the tool (yes/maybe = 66%). Participants 
generally found the historical score function useful, enabling 
monitoring of their condition overtime and helping with self-
management approaches. 
Usability
Analysis of participant views on ease of tool use, likes and 
dislikes resulted in the generation of eight codes (Table 7). 
Participants liked the ability to see plots of their BASDAI 
scores and would have liked more information graphics (e.g. 
physical activity and averages for other users) to assist in 
monitoring their condition. There were split opinions among 
the participants regarding the tool layout, reflecting personal 
preference. A number of participants found recording physi-
cal  activity  difficult  (Table  7).  The  use  of  an  activity  list  as 
a memory prompt or a smartphone version allowing activity 
recording to occur at the time was proposed by participants. 
Additionally, participants would have liked a mechanism to 
record other influencing factors such as medication changes 
or periodic medicine use, weather, diet, reasons for no/low 
activity (e.g. injury/flare up), non-AS ill health, AS associated 
conditions (e.g. iritis/Crohns), alternative therapies (e.g. mas-
sage) and holidays. 
Some participants reported technical problems with the web-
site (e.g. compatibility issues and screen freezing during data 
input), with 28 enquiries to the technical support team. It was 
possible to resolve 11 of these enquiries, which predominantly 
related to problems caused when using certain browsers. 
Further specific information was needed and not obtained for 
seven  enquiries,  thus  preventing  resolution.  Further  seven 
enquiries could not be  resolved, despite  the use of browser 
mimic software, and due to the lack of an email address, it was 
not possible to follow up on three enquiries.
Comments received
Comments  received  via  the  project website  fell  into  six main 
themes: statements of support (n  =  17),  eligibility  enquiries  
(n = 8), comments regarding periodic unavailability (n = 3), tech-
nical problems (n = 4) and participation queries regarding confi-
dentiality and time to complete (n = 2). Several comments were 
also received regarding the module content, which reflected the 
complex nature of AS and feedback received in the exit ques-
tionnaire, namely regarding recording of additional information, 
e.g. medication and diet, or that data recording did not reflect 
the complexity of AS (e.g. no functional measurements)or the 
detailed nuances of exercise (n = 3). 
In this pilot study, participants were not asked to modify 
their physical activity levels; however, participants noted that 
tool use (including historical scores) helped them to engage 
with the role of physical activity in their condition. However, 
there was no evidence of an overall increase of physical 
activity during the study duration. Therefore, tool use may 
have enabled participants to engage with their activity and 
condition, but did not necessarily serve as an effective moti-
vator for the majority. 
Strengths and weaknesses 
This study was successful in collecting research data of 223 
participants, who were representative of AS populations, 
using an eHealth tool. Whilst not all individuals responded 
weekly over the 12-week-period sensitivity, analyses includ-
ing only participants that had completed at least 6 weeks 
revealed generally similar findings (Table S3). 
However, user-orientated platforms present a number of 
challenges to data collection. The challenges include self-
assessment, which is subjective by nature and can therefore 
lack precision and allows for a range of interpretation and 
therefore no standardised approach to comprehending or 
responding to questions or inputting data,32 even when stan-
dardised collection tools (e.g. IPAQ) are utilised. Furthermore, 
there is always a risk of recruitment bias. In this pilot study, 
NASS was instrumental in recruitment and although other 
recruitment approaches were used, it is likely that this cohort 
was dominated by NASS members, who are likely to be of 
middle to high socioeconomic status (who are more likely to 
engage in e-health/technology-based research33), consist of 
potentially more severe AS cases and be particularly engaged 
with their condition. In this pilot study, we were unable to 
account for potential biases due to the socioeconomic status 
of the participants; however, socioeconomic status should 
not influence the observed associations between AS sever-
ity and exercise observed here, which utilised FE models to 
eliminate omitted variable bias. It should also be noted that 
due to study duration, it was not possible to account for sea-
sonal impacts on physical activity or symptoms and that due 
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Table 6 Reasons for not reporting/completing data entry
N
Not receiving reminder emails (including delivery to spam folders) 26
Unavailability due to holidays, ill health (including fatigue) or just being too busy 21
Forgetting 9
Technical, computer and internet problems 6
Actively choosing not complete data entry due to non-AS ill health and not wishing to skew results 1
Note: In total, n = 93 (includes findings from one early withdrawal participant); however, not all 
participants provided free-text comments (applicable for 34 of 93) and hence were excluded 
from the above list. Additionally, participants had the option to select more than one reason.
Table 7 Themes, codes, counts and exerts from usability exit question
Question: Did you find the tool easy to use, and what did or didn’t you like about the tool?
Response N (%) Codes on detail N Illustrative Example Quotes
n/a or no 
clear answer
20 (22)
Easy 67 (72) Liked format e.g. 
standardisation, layout 
5 ‘Yes easy, good to have standardised pro forms every week’
‘its good how the page keeps moving up automatically’
Liked monitoring scores 2 ‘Yes it is very easy and I liked the graphical representation of the data’
Liked effect of awareness 
raising / thought 
provoking
2 ‘Yes - just made me think carefully about my condition’
‘Very easy, didn’t take much time, really useful for making me think about my own 
behaviours and pain’
Had 
difficulties
3 (3.5) Disliked format e.g. 
standardisation, layout
6 ‘yes. I don’t like the fact it scrolls down automatically - on the marker sections’
‘Found it relatively easy to use sometimes hard to use the markers though’
‘yes, although sometimes the answer is between stated levels’
‘Sometimes the questions were too generic but on the whole helpful’ 
‘didn’t like all of the save and continue buttons’
Technical problems 6 ‘Programme did not always respond’
‘It was fantastic, until the links stopped coming’
‘It’s difficult to select a score of zero’
‘Yes it was easy to use, however things not so good is the that the tool crashes and 
logs out if you press return’
‘t could not be used on a phone by those like me who are unable to sit’
No 3 (3.5) Difficult to record physical 
activity
5 ‘Easy, but difficult to categorise some activities, e.g. moderate exercise doubles 
tennis for me would be vigorous’ 
‘It is not easy to state how much time I spend each day doing various exercises 
because I swim on 2 days a week I take a long walk one day a week and so on’
‘I would have preferred a table to complete, as each week and day was different in 
terms of activity’
Disliked time / frequency 
of use
3 ‘yes if a bit long’
‘fortnightly would be better’
‘Should be done on a monthly basis’
Felt it was too simplistic 6 ‘easy to use but bit of a blunt instrument in providing details of daily activities’
‘sometimes other medical factors effect the spondy scores, no scoring mechanism 
allows for this effect’
‘easy to use, but not linked other factors, e.g. weather, different location, change in 
medication, or diet change’
‘I would have liked to be able to expand some of the answers”
Note: n = 93 (includes findings from 1 early withdrawal participant); however, not all participants provided free-text comments.
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to the nature of the data, the direction of associations, i.e. 
cause and effect, could not be established. 
CONCLUDING REMARKS 
This pilot study was successful in its aim to develop an eHealth 
tool that was user friendly, participant engaging and was able 
to generate data suitable for epidemiological studies. The AS 
Observer was generally considered useful by participants, as 
evidenced by two-thirds of users intending to continue moni-
toring their condition. The pilot study highlighted the impor-
tance of using reminder/prompt systems, providing access to 
personal data stores for monitoring purposes, and that self-
reporting physical activity was challenging. Future studies 
should where possible include participant tailored elements to 
provide the opportunity to record the impact of other influenc-
ing factors for chronic, variable conditions like AS.
Statistical analysis supported the use of physical activ-
ity  in AS management  to  benefit  overall  disease activity, 
stiffness, tenderness and pain, but not fatigue. However, 
adjustment for the howRu data attenuated the associations 
between physical activity and both peripheral and axial 
pain,  highlighting  the  importance  of  quality  of  life  in  this 
relationship. Increased BASDAI was associated with the 
mental health dimension of the howRu tool (Table 4) and 
therefore increasing physical activity may have multiple 
benefits  either  directly  via  reduced  disease  activity  and/
or  improved quality of  life. This study suggests guidance 
around physical activity needs to consider patient specific 
factors including gender, disease duration and mental 
health status.
Ultimately, eHealth tools such as the AS Observer, which 
may have a key role to play in clinical settings in the future 
(e.g. self-management of chronic conditions and clinician 
remote monitoring of patients), also serve as a potential 
data source for research purposes. Although this pilot 
study only had a relatively small cohort (n = 223), scal-
ing up participation in AS disease monitoring tools could 
provide a valuable means to collect data and facilitate 
research,  which  will  ultimately  benefit  patients  and  clini-
cians alike by providing real-time monitoring and indicating 
potential treatment pathways.
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